N17 N18 Z94.0 Z49
Conditions
Interventions
Group 1: -No AKI
PenKid will be determined in patients without acute kidney injury (AKI) that are admitted to the department of nephrology or one of the aforementioned intensive care units with every
OR increase in serum-creatinine to 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days
OR Urine volume 7d)
PenKid will be determined in patients with progressive acute kidney injury (AKI) or acute kidney disease that are admitted to the department of nephrology or one of the aforementio
Sponsors
Nierenzentrum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients admitted to the surgical intensive care units of University Hospital Heidelberg (departments E0, E99, F99), gastroenterological intensive care units as well as patients admitted to general ward at Nierenzentrum Heidelberg. The study will begin on November 2nd 2021 and end on November 30th 2022. In this time, all patients on the above mentioned departments will be included. The study was prolonged until end of July 2023.
Exclusion criteria
Exclusion criteria: Below 18 years of age, Incomplete documentation regarding patient information/history
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Renal outcome as estimated by PenKid, Serum-Creatinine, Diuresis, renal replacement therapy 7, 30, 90, 180 days after admission | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient outcome (Mortality) 7, 30, 90, 180 days after admission | — |
Countries
Germany
Contacts
Public ContactChristian Nußhag
Nierenzentrum Heidelberg
Outcome results
None listed